Immune checkpoints such as programmed death ligand 1 (PD-L1; encoded by the CD274 gene) and PD-1 are elevated in cancers and their activated interaction results in the evasion of immune surveillance and the facilitation of tumor malignant transformation [26,27,28]. The gene discussed is CD274; the disease is cancer.